GlassScriptPhysician profile
George E Chaux
NPI 1619938941
$19,442.52
in general payments reported to CMS, 2019-2025
26 companies · $1,134 in 2025
The $1,134 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,467 · 2020: $5,168 · 2021: $812 · 2022: $1,036 · 2023: $5,664 · 2024: $2,161 · 2025: $1,134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,605 · Consulting Fee: $2,500 · Food and Beverage: $2,330 · Education: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,605.47 |
| Consulting Fee | $2,500.00 |
| Food and Beverage | $2,330.25 |
| Education | $1,523.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle Biologics, INC | $8,347.81 | 2019-2023 | Photofrin |
| Intuitive Surgical, INC. | $6,576.94 | 2019-2024 | Da Vinci Surgical System |
| Pulmonx Corporation | $1,559.20 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Zoll Medical Corporation | $406.67 | 2021 | |
| Serpex Medical INC | $322.85 | 2025 | |
| Ethicon INC. | $237.12 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $226.46 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $200.00 | 2024 | |
| United Therapeutics Corporation | $192.98 | 2019-2024 | Tyvaso |
| Olympus America INC. | $186.42 | 2025 | Spiration Valve System |
| Electromed, INC. | $175.68 | 2025 | Smartvest |
| La Jolla Pharmaceutical Company | $142.85 | 2022 | |
| Allergan, INC. | $136.89 | 2019 | |
| Insmed, INC. | $114.12 | 2025 | Arikayce, Brinsupri |
| Glaxosmithkline, LLC. | $110.98 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $103.79 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Vapotherm INC | $91.92 | 2022 | |
| Steris Corporation | $89.04 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $65.47 | 2024 | Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.71 | 2024-2025 | Ofev, Jascayd |
| Boston Scientific Corporation | $37.00 | 2022 | |
| Pfizer INC. | $25.33 | 2025 | |
| Amgen INC. | $21.34 | 2024 | Tezspire |
| Philips North America LLC | $18.05 | 2024 | (Ak6) Vest Therapy |
| Ambu INC. | $3.90 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Chaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.